Wesfarmers released its 2025 full-year results this morning, reporting a net profit after tax of $2,926 million.
The group had a total revenue of $45.7 billion, up 3.4% on FY24.
Earnings for Wesfarmers Health, which includes Priceline, InstantScripts and API, came in at $64 million, an increase of 28% on the $50 million in FY24.
Priceline Pharmacy’s headline network sales, including dispensary sales, increased 11.9%.
“Priceline Pharmacy’s Retail sales were supported by network expansion, price reductions on key value lines, the launch of new and exclusive brands, and the ongoing contribution of the Sister Club, Australia’s largest health and beauty loyalty program with 9.6 million members,” the company stated.
According to the statement, Wesfarmers Health is well positioned to improve long-term earnings and returns, driven by Priceline network growth, as it capitalises on growing consumer demand for health and wellness.
More details in today’s issue of Pharmacy Daily.
